Transforming growth factor-β-induced KDM4B promotes chondrogenic differentiation of human mesenchymal stem cells

Stem Cells

Volumn 34, Issue 3, 2016, Pages 711-719

  Lee, Hye Lim ^a   Yu, Bo ^a   Deng, Peng ^a   Wang, Cun Yu ^a   Hong, Christine ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Chondrogenesis; Differentiation; KDM4B; Mesenchymal stem cells; SOX9; Transforming growth factor

Indexed keywords

KDM4B PROTEIN; PROTEIN; SHORT HAIRPIN RNA; SMAD3 PROTEIN; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; HISTONE DEMETHYLASE; KDM4B PROTEIN, HUMAN; SMAD3 PROTEIN, HUMAN; SOX9 PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; EPIGENETICS; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; REGULATORY MECHANISM; BIOSYNTHESIS; BONE DEVELOPMENT; CARTILAGE; CELL LINE; CHONDROCYTE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; GROWTH, DEVELOPMENT AND AGING; MESENCHYMAL STROMA CELL; METABOLISM; REGENERATION; SIGNAL TRANSDUCTION;

CARTILAGE; CELL DIFFERENTIATION; CELL LINE; CHONDROCYTES; CHONDROGENESIS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; PROMOTER REGIONS, GENETIC; REGENERATION; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; SOX9 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

EID: 84947251698     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2231     Document Type: Article

References (54)

1. Salem HK, Thiemermann C,. Mesenchymal stromal cells: Current understanding and clinical status. Stem Cells 2010; 28: 585-596.
2. Arpornmaeklong P, Brown SE, Wang Z, et al., Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cells Dev 2009; 18: 955-968.
3. Kolf CM, Cho E, Tuan RS,. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 2007; 9: 204.
4. Quarto R, Mastrogiacomo M, Cancedda R, et al., Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001; 344: 385-386.
5. Buckwalter JA,. Articular cartilage: Injuries and potential for healing. J Orthop Sports Phys Ther 1998; 28: 192-202.
6. Risbud MV, Sittinger M,. Tissue engineering: Advances in in vitro cartilage generation. Trends Biotechnol 2002; 20: 351-356.
7. Wakitani S, Imoto K, Yamamoto T, et al., Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 2002; 10: 199-206.
8. Charbord P,. Bone marrow mesenchymal stem cells: Historical overview and concepts. Hum Gene Ther 2010; 21: 1045-1056.
9. Indumathi S, Harikrishnan R, Rajkumar JS, et al., Immunophenotypic comparison of heterogenous non-sorted versus sorted mononuclear cells from human umbilical cord blood: A novel cell enrichment approach. Cytotechnology 2015; 67: 107-114.
10. Li O, Tormin A, Sundberg B, et al., Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies. PLoS One 2013; 8: e55319.
11. Im GI, Jung NH, Tae SK,. Chondrogenic differentiation of mesenchymal stem cells isolated from patients in late adulthood: the optimal conditions of growth factors. Tissue Eng 2006; 12: 527-536.
12. Lorda-Diez CI, Montero JA, Martinez-Cue C, et al., Transforming growth factors beta coordinate cartilage and tendon differentiation in the developing limb mesenchyme. J Biol Chem 2009; 284: 29988-29996.
13. Tayalia P, Mooney DJ,. Controlled growth factor delivery for tissue engineering. Adv Mater 2009; 21: 3269-3285.
14. Heldin CH, Miyazono K, ten Dijke P,. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390: 465-471.
15. Derynck R, Zhang YE,. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425: 577-584.
16. Sporn MB, Roberts AB,. The transforming growth factor-betas: Past, present, and future. Ann N Y Acad Sci 1990; 593: 1-6.
17. Ng LJ, Wheatley S, Muscat GE, et al., SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol 1997; 183: 108-121.
18. Bi W, Deng JM, Zhang Z, et al., Sox9 is required for cartilage formation. Nat Genet 1999; 22: 85-89.
19. Lefebvre V, Behringer RR, de Crombrugghe B,. L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage 2001; 9 (Suppl A): S69-S75.
20. Ikeda T, Kamekura S, Mabuchi A, et al., The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum 2004; 50: 3561-3573.
21. Han Y, Lefebvre V,. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol Cell Biol 2008; 28: 4999-5013.
22. Dwivedi RS, Herman JG, McCaffrey TA, et al., Beyond genetics: Epigenetic code in chronic kidney disease. Kidney Int 2011; 79: 23-32.
23. Galm O, Esteller M,. Beyond genetics-The emerging role of epigenetic changes in hematopoietic malignancies. Int J Hematol 2004; 80: 120-127.
24. Li YY,. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease. World J Gastroenterol 2012; 18: 6546-6551.
25. Aranda P, Agirre X, Ballestar E, et al., Epigenetic signatures associated with different levels of differentiation potential in human stem cells. PLoS One 2009; 4: e7809.
26. Hermann A, Maisel M, Storch A,. Epigenetic conversion of human adult bone mesodermal stromal cells into neuroectodermal cell types for replacement therapy of neurodegenerative disorders. Expert Opin Biol Ther 2006; 6: 653-670.
27. Teven CM, Liu X, Hu N, et al., Epigenetic regulation of mesenchymal stem cells: A focus on osteogenic and adipogenic differentiation. Stem Cells Int 2011; 2011: 201371.
28. Agger K, Christensen J, Cloos PA, et al., The emerging functions of histone demethylases. Curr Opin Genet Dev 2008; 18: 159-168.
29. Klose RJ, Kallin EM, Zhang Y,. JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet 2006; 7: 715-727.
30. Shi Y,. Histone lysine demethylases: Emerging roles in development, physiology and disease. Nat Rev Genet 2007; 8: 829-833.
31. Ye L, Fan Z, Yu B, et al., Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs. Cell Stem Cell 2012; 11: 50-61.
32. Fodor BD, Kubicek S, Yonezawa M, et al., Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev 2006; 20: 1557-1562.
33. Cloos PA, Christensen J, Agger K, et al., The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 2006; 442: 307-311.
34. Whetstine JR, Nottke A, Lan F, et al., Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 2006; 125: 467-481.
35. Choo A, Lim SK,. Derivation of mesenchymal stem cells from human embryonic stem cells. Methods Mol Biol 2011; 690: 175-182.
36. Russell KC, Phinney DG, Lacey MR, et al., In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 2010; 28: 788-798.
37. Fan Z, Yamaza T, Lee JS, et al., BCOR regulates mesenchymal stem cell function by epigenetic mechanisms. Nat Cell Biol 2009; 11: 1002-1009.
38. Park BK, Zhang H, Zeng Q, et al., NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med 2007; 13: 62-69.
39. Klose RJ, Bird AP,. Genomic DNA methylation: The mark and its mediators. Trends Biochem Sci 2006; 31: 89-97.
40. Furumatsu T, Tsuda M, Yoshida K, et al., Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J Biol Chem 2005; 280: 35203-35208.
41. Hattori T, Coustry F, Stephens S, et al., Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5. Nucleic Acids Res 2008; 36: 3011-3024.
42. Tsuda M, Takahashi S, Takahashi Y, et al., Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9. J Biol Chem 2003; 278: 27224-27229.
43. Liu CJ, Zhang Y, Xu K, et al., Transcriptional activation of cartilage oligomeric matrix protein by Sox9, Sox5, and Sox6 transcription factors and CBP/p300 coactivators. Front Biosci 2007; 12: 3899-3910.
44. Hata K, Takashima R, Amano K, et al., Arid5b facilitates chondrogenesis by recruiting the histone demethylase Phf2 to Sox9-regulated genes. Nat Commun 2013; 4: 2850.
45. Kim K, K. I., Park YS, Im GI,. Changes in the epigenetic status of the SOX-9 promoter in human osteoarthritic cartilage. J Bone Miner Res 2013; 28: 1050-1060.
46. Herlofsen SR, Bryne JC, Hoiby T, et al., Genome-wide map of quantified epigenetic changes during in vitro chondrogenic differentiation of primary human mesenchymal stem cells. BMC Genomics 2013; 14: 105.
47. Northcott PA, Nakahara Y, Wu X, et al., Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 2009; 41: 465-472.
48. Li W, Zhao L, Zang W, et al., Histone demethylase JMJD2B is required for tumor cell proliferation and survival and is overexpressed in gastric cancer. Biochem Biophys Res Commun 2011; 416: 372-378.
49. Toyokawa G, Cho HS, Iwai Y, et al., The histone demethylase JMJD2B plays an essential role in human carcinogenesis through positive regulation of cyclin-dependent kinase 6. Cancer Prev Res 2011; 4: 2051-2061.
50. Fu L, Chen L, Yang J, et al., HIF-1alpha-induced histone demethylase JMJD2B contributes to the malignant phenotype of colorectal cancer cells via an epigenetic mechanism. Carcinogenesis 2012; 33: 1664-1673.
51. Tang Y, Wu X, Lei W, et al., TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 2009; 15: 757-765.
52. Medici D, Shore EM, Lounev VY, et al., Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 2010; 16: 1400-1406.
53. Kronenberg HM,. Gs signaling in osteoblasts and hematopoietic stem cells. Ann N Y Acad Sci 2010; 1192: 327-329.
54. Huebsch N, Arany PR, Mao AS, et al., Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater 2010; 9: 518-526.